More on JBIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+24.4% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Jade Biosciences (NQ:JBIO)
Delayed: 20.86 +0.38 (1.86%)
Prev. Close $20.48  
Open$19.88 
52 Wk High$ 
52 Wk Low$ 
Day High$21.45 
Day Low$19.40 
P/E N/A  
EPS$ 
Volume659,521 


Jul 17, 2026 04:06 PM Form SCHEDULE 13G Jade Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Jul 8, 2026 05:44 PM Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Janus Henderson Group Ltd.
Jul 1, 2026 05:13 PM Jade Biosciences licenses antibody program from Paragon Therapeutics
Jul 1, 2026 04:41 PM Form 8-K Jade Biosciences, Inc. For: Jun 29
Jun 26, 2026 09:21 PM Form 4 Jade Biosciences, Inc. For: Jun 25 Filed by: Eisner Mark
Jun 26, 2026 09:11 PM Form 3 Jade Biosciences, Inc. For: Jun 25 Filed by: Eisner Mark
Jun 26, 2026 07:16 AM Form 8-K Jade Biosciences, Inc. For: Jun 25
Jun 26, 2026 07:01 AM Jade Biosciences names Mark Eisner to its board of directors
Jun 26, 2026 07:00 AM Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
Jun 15, 2026 03:01 AM UBS Starts Jade Biosciences (JBIO) at Buy
View All Articles

Entities mentioned with JBIO

View All Entities